AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3…
Atos Group receives confirmatory offer from the French State to acquire part of its former Advanced Computing business
Press release Atos Group receives confirmatory offer from the French State to…